Christopher Abel Cano, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2016 | 520 | 0.190 |
Why?
|
| Immunologic Factors | 2 | 2016 | 1575 | 0.140 |
Why?
|
| Influenza Vaccines | 2 | 2022 | 733 | 0.140 |
Why?
|
| Leukoencephalopathy, Progressive Multifocal | 1 | 2016 | 135 | 0.130 |
Why?
|
| Pulmonary Surfactant-Associated Protein A | 1 | 2012 | 32 | 0.110 |
Why?
|
| Cerebellum | 1 | 2017 | 1490 | 0.090 |
Why?
|
| Drug Monitoring | 1 | 2016 | 956 | 0.090 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2012 | 644 | 0.080 |
Why?
|
| Pulmonary Fibrosis | 1 | 2012 | 526 | 0.080 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2011 | 570 | 0.070 |
Why?
|
| Gingiva | 1 | 2008 | 388 | 0.070 |
Why?
|
| Simian immunodeficiency virus | 1 | 2011 | 846 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2012 | 2556 | 0.060 |
Why?
|
| Squalene | 1 | 2022 | 32 | 0.050 |
Why?
|
| Polysorbates | 1 | 2022 | 41 | 0.050 |
Why?
|
| Esophagus | 1 | 2008 | 1017 | 0.050 |
Why?
|
| Powders | 1 | 2022 | 80 | 0.050 |
Why?
|
| Excipients | 1 | 2022 | 96 | 0.050 |
Why?
|
| HIV | 1 | 2008 | 1600 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2008 | 1837 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2011 | 4379 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2008 | 3465 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2022 | 1000 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 8425 | 0.040 |
Why?
|
| Mitoxantrone | 1 | 2016 | 149 | 0.030 |
Why?
|
| Purkinje Cells | 1 | 2017 | 223 | 0.030 |
Why?
|
| Maze Learning | 1 | 2017 | 478 | 0.030 |
Why?
|
| Smell | 1 | 2017 | 243 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2016 | 323 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 12071 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2008 | 13029 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 10163 | 0.030 |
Why?
|
| Rest | 1 | 2017 | 900 | 0.030 |
Why?
|
| Cercocebus atys | 1 | 2011 | 12 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 3164 | 0.020 |
Why?
|
| Social Behavior | 1 | 2017 | 1128 | 0.020 |
Why?
|
| Unfolded Protein Response | 1 | 2012 | 230 | 0.020 |
Why?
|
| Behavior, Animal | 1 | 2017 | 1882 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 13019 | 0.020 |
Why?
|
| Mutation | 1 | 2012 | 29717 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2017 | 2971 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2012 | 1538 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 2790 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2011 | 1056 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2011 | 1049 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9735 | 0.020 |
Why?
|
| Pedigree | 1 | 2012 | 4646 | 0.020 |
Why?
|
| Th17 Cells | 1 | 2011 | 765 | 0.020 |
Why?
|
| Animals | 4 | 2022 | 168561 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2011 | 2211 | 0.010 |
Why?
|
| Mice | 2 | 2022 | 81045 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2012 | 3493 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2378 | 0.010 |
Why?
|
| Viral Load | 1 | 2011 | 3292 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2016 | 3076 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4751 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2008 | 2524 | 0.010 |
Why?
|
| Lung | 1 | 2012 | 9826 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2011 | 7873 | 0.010 |
Why?
|
| Humans | 5 | 2017 | 742088 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 56350 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 35342 | 0.010 |
Why?
|
| Child | 1 | 2017 | 77478 | 0.010 |
Why?
|
| Male | 2 | 2017 | 349538 | 0.000 |
Why?
|
| Female | 2 | 2017 | 379592 | 0.000 |
Why?
|
| Middle Aged | 1 | 2008 | 213127 | 0.000 |
Why?
|
| Adult | 1 | 2008 | 213712 | 0.000 |
Why?
|